Health & Wellness | 健康知识库

by 大牙哥

Benefits & Risks of Peptide Therapeutics for Physical & Mental Health

5分钟阅读

Benefits & Risks of Peptide Therapeutics for Physical & Mental Health

Summary

This episode provides a comprehensive overview of therapeutic peptides currently in use for tissue repair, metabolism and growth, longevity, and mood and libido enhancement. Andrew Huberman explains the biology of how peptides work, organizes them into clear categories, and outlines both the potential benefits and significant risks associated with their use. A strong emphasis is placed on sourcing peptides safely through board-certified physicians and licensed compounding pharmacies.

Key Takeaways

  • Peptides are small proteins (2–100 amino acids) with wide-ranging, or pleiotropic, effects — they almost never do just one thing
  • Three sourcing tiers exist: FDA-approved prescription peptides (safest), gray-market peptides (variable quality), and black-market peptides (avoid entirely due to contamination risks including lipopolysaccharide or LPS)
  • BPC-157 shows strong animal evidence for tissue repair via angiogenesis and fibroblast migration, but carries real tumor-growth risk due to VEGF upregulation
  • Growth hormone secretagogues (Type 1: Sermorelin, Tesamorelin; Type 2: Ipamorelin, Hexarelin) can increase growth hormone and IGF-1, but carry risks including tumor promotion, receptor desensitization, and sleep disruption
  • Epithalon is the primary longevity-focused peptide, thought to restore telomere length and regulate circadian/melatonin patterns — but human clinical trial data are largely absent
  • Melanotan peptides and PT-141 (Bremelanotide) activate the melanocortin system to increase libido, mood, and skin pigmentation — PT-141 is FDA-approved for premenopausal hypoactive sexual desire disorder
  • Timing matters: Most growth hormone peptides should be taken 1.5–2 hours after eating and at night to align with the body’s natural GH pulse during sleep
  • Anyone with known tumors or cancer should avoid BPC-157 and growth hormone secretagogues, as both can accelerate tumor growth

Detailed Notes

What Is a Peptide?

  • A peptide is a small protein composed of 2 to ~100 amino acids arranged in a chain
  • Combining peptides creates polypeptides, which form many proteins in the body
  • Well-known natural peptides include insulin and oxytocin
  • Most peptides have pleiotropic effects — they activate multiple cell pathways simultaneously, affecting different tissues depending on context, dose, and timing
  • This makes predicting effects and side effects complex; targeted single-effect peptide therapy is rare

Sourcing and Safety

  • Prescription peptides (FDA-approved, from pharma or compounding pharmacies): Safest — LPS is removed during manufacturing
  • Gray-market peptides: Can be purchased online; often lack LPS removal; variable purity
  • Black-market peptides: High contamination risk; labels may not match contents — strongly discouraged
  • Lipopolysaccharide (LPS) contamination from manufacturing can trigger cumulative immune responses and must be removed before use
  • Working with a board-certified physician is strongly recommended for anyone considering therapeutic peptides

Category 1: Tissue Rejuvenation and Repair

BPC-157 (Body Protection Compound)

  • Naturally derived from gastric juice; synthesized as BPC-157
  • Mechanism: Promotes angiogenesis via upregulation of VEGF and eNOS (endothelial nitric oxide synthase); encourages fibroblast migration; increases growth hormone receptor expression at injury sites
  • Animal evidence: Robust data on sciatic nerve, Achilles tendon, and ligament repair — including complete transection recovery in rats
  • Human evidence: Largely anecdotal; no rigorous clinical trials
  • Typical dosage: 300–500 micrograms, subcutaneously or intramuscularly, 2–5x per week for ~8 weeks; cycle off for 8–10 weeks
  • Risks:
    • Stimulates VEGF → promotes tumor vascularization (opposite of anti-cancer drugs like Avastin, which inhibit VEGF)
    • People with known cancer, tumors, or eye diseases involving abnormal vessel growth (e.g., wet AMD) should avoid it
    • Whether systemic vs. local injection is more effective remains unresolved

Thymosin Beta-4 / TB-500

  • Naturally secreted by the thymus in children; associated with faster wound healing and minimal scarring in youth
  • TB-500 is a truncated, lab-synthesized version of Thymosin Beta-4 with similar but slightly different action and longer duration
  • Mechanism: Promotes stem cell proliferation, extracellular matrix growth, and migration of multiple cell types associated with wound repair
  • Does not significantly impact the growth hormone pathway
  • Commonly stacked with BPC-157
  • Evidence base: Primarily animal studies; anecdotal human reports

Category 2: Metabolism and Growth (Growth Hormone Secretagogues)

Background on Growth Hormone

  • Secreted by the anterior pituitary, stimulated by growth hormone–releasing hormone (GHRH) from the hypothalamus
  • Naturally peaks during the early phase of sleep; declines ~15% per decade after age 30
  • Stimulates the liver to produce IGF-1, which drives tissue growth, metabolic efficiency, and energy production (ATP)
  • Taking exogenous growth hormone directly creates negative feedback, suppressing the body’s own production

Type 1 Peptides (GHRH Mimetics)

These mimic growth hormone–releasing hormone and stimulate the pituitary directly.

  • Sermorelin

    • FDA-approved for short stature; used off-label for GH augmentation
    • Dosage: 200–400 mcg at night, 3–5x per week
    • Increases deep (slow-wave) sleep; may reduce REM sleep — Huberman noted personally stopping due to this effect
    • Lower desensitization risk than Type 2 peptides

  • Tesamorelin (Egrifta)

    • FDA-approved for visceral adiposity in HIV patients
    • Longer-lasting than Sermorelin; typically taken ~3x per week
    • Reduces visceral fat; similar benefits to Sermorelin

  • CJC-1295

    • Contains a Drug Affinity Complex (DAC) making it very long-lasting; dosed 1–2x per week
    • One death occurred in clinical trials (cardiovascular event — possibly related to fluid retention)
    • Not recommended when Sermorelin or Tesamorelin are available as safer alternatives

Type 2 Peptides (Ghrelin Mimetics)

These mimic ghrelin, stimulating GH release through a separate receptor pathway. They also increase hunger and anxiety as side effects.

  • Ipamorelin

    • Increases GH directly and suppresses somatostatin (the brake on GH release)
    • Improves deep sleep; hunger and anxiety side effects milder than other Type 2 options

  • Hexarelin

    • Most potent GH stimulator (2–3x the pulse of other secretagogues)
    • Major risk: Can cause receptor desensitization/internalization — potentially permanently shutting down the GHRH receptor pathway
    • Raises prolactin (suppresses libido), causes fluid retention and malaise

  • GHRP-2, GHRP-3, GHRP-6

    • Potent GH stimulators; significantly raise cortisol (>2x) — problematic for evening use when cortisol should be low

  • MK-677

    • Oral (non-injectable) ghrelin mimetic
    • Same risk profile as other Type 2 peptides: elevated cortisol and prolactin

General Growth Hormone Risks

  • Indiscriminate tissue growth → accelerates tumor growth
  • Physical changes with prolonged use: carpal tunnel, joint changes, facial bone thickening, distended abdomen (“GH gut”)
  • Combining BPC-157

关系图谱